Company attributes
B2X
Founder
AngelList URL
Pitchbook URL
Accelerator
Accelerator Batch
Number of Employees (Ranges)
11 – 500
Number of Employees
3080
Full Address
Washington, D.C., US
Investors
Founded Date
2019
0Total Funding Amount (USD)
40,000,000
Latest Funding Round Date
September 16, 2021
Glassdoor ID
Board of Directors
Key People
Latest Funding Type
Wellfound ID
Country
Other attributes
Announcement URL
Blog
Company Operating Status
Active
Latest Funding Round Amount (USD)
25,000,000
Medium URL
Partner Organizations
Public/Private
Private
Y Combinator URL
The company is engaged in health technology platform, creates a variety of data sets to uncover scientific discoveries, as well as improve the results of diagnosis and treatment in Africa and around the world.
Them proprietary Genomics Infrastructure & Insights Ecosystem (GENIISYS™) platform contains highly curated genetic, clinical and phenotypic data from which they generate insights that lead to new treatments and diagnostics.
GENIISYS™ underpins three distinct, but synergistic business lines, which converge to deliver on the promise and power of equalizing precision medicine for all.
These business lines:
- drug discovery
- molecular diagnostics
- clinical trial programs – are specifically inclusive of African populations.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
